Review Article
Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis
Table 2
Patient population and clinical scenario among included studies.
| Patient population | Study | Investigational drug |
| STEMI | APEX-MI [28] | Pexelizumab | COMMA [16] | COMPLY [16] | VCU-ART3 [34] | Anakinra | NSTEMI | MRC-ILA Heart Study [35] | Anakinra | MI (STEMI and NSTEMI) | CANTOS [17] | Canakinumab | LATITUDE TIMI 60 [43] | Losmapimod | COLCOT [37] | Colchicine | ACS (STEMI, NSTEMI, or UA) | SOLID TIMI 52 [38] | Darapladib | FRANCIS [41] | Varespladib | VISTA-16 [40] | Varespladib | CABG | PRIMO CABG 1 [32] | Pexelizumab | PRIMO CABG 2 [31] | Pexelizumab Study Investigators [30] | SELECT-CABG [42] | Inclacumab | Stable CAD | STABILITY [39] | Darapladib | LoDoCo [36] | Colchicine |
|
|
Study with subgroup analysis of its primary end points. |